Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -16.10x is 11% above its 1-year average of -18.14x, around the middle of its 1-year range (-34.37x–2.11x).
8.13% below its 12-month average of -14.89x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -17.49x.
INTEREST COVERAGE RATIO
-16.10x
INTEREST COVERAGE RATIO AVG TTM
-14.89x
INTEREST COVERAGE RATIO AVG 3Y
-18.14x
INTEREST COVERAGE RATIO AVG 5Y
-18.14x
INTEREST COVERAGE RATIO AVG 10Y
-90.83x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-8.13%
CURRENT VS 3Y AVG
+11.23%
CURRENT VS 5Y AVG
+11.23%
CURRENT VS 10Y AVG
+82.27%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.23x
median of 360 covered companies
CURRENT VS SECTOR MEDIAN
-280.61%
vs the sector median at left
Editas Medicine, Inc.
Market Cap
$432.00M
Interest Coverage Ratio
-16.10x
TTM Avg
-14.89x
3Y Avg
-18.14x
5Y Avg
-18.14x
Market Cap
$431.90M
Interest Coverage Ratio
-35.51x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$441.36M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$411.99M
Interest Coverage Ratio
-21.38x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$408.14M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$411.45M
Interest Coverage Ratio
-404.95x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$408.54M
Interest Coverage Ratio
-375.67x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$457.20M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$460.20M
Interest Coverage Ratio
-17.61x
TTM Avg
2.56x
3Y Avg
1.47x
5Y Avg
1.63x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Editas Medicine, Inc. (EDIT) | $432.00M | -16.10x | -14.89x | -18.14x | -18.14x |
| Capricor Therapeutics, Inc. (CAPR)vs › | $431.90M | -35.51x | N/A | N/A | N/A |
| Assembly Biosciences, Inc. (ASMB)vs › | $441.36M | N/A | N/A | N/A | N/A |
| Carlsmed, Inc. (CARL)vs › | $411.99M | -21.38x | N/A | N/A | N/A |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $408.14M | N/A | N/A | N/A | N/A |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $411.45M | -404.95x | N/A | N/A | N/A |
| Shoulder Innovations, Inc. (SI)vs › | $408.54M | -375.67x | N/A | N/A | N/A |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $457.20M | N/A | N/A | N/A | N/A |
| NeoGenomics, Inc. (NEO)vs › | $460.20M | -17.61x | 2.56x | 1.47x | 1.63x |
| Kamada Ltd. (KMDA)vs › | $460.98M | 30.36x | 30.37x | 18.36x | 29.15x |
Interest Coverage
-16.1x
Debt/Equity
0.15
Current Ratio
3.19
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -17.49x |
| 2026-03-31 | -23.32x |
| 2025-12-31 | 2.11x |
| 2025-09-30 | -10.23x |
| 2025-06-30 | -25.52x |
| 2025-03-31 | -34.37x |
| 2017-09-30 | -581.50x |
| 2017-06-30 | -58.55x |
| 2017-03-31 | -50.21x |
| 2016-12-31 | -109.20x |
| 2015-12-31 | -363.91x |
| 2015-09-30 | -167.77x |
| 2015-06-30 | -305.76x |
| 2015-03-31 | -166.48x |
| 2014-12-31 | -305.18x |
